Fisetin Protects HaCaT Human Keratinocytes from Fine Particulate Matter (PM2.5)-Induced Oxidative Stress and Apoptosis by Inhibiting the Endoplasmic Reticulum Stress Response. 2021

Ilandarage Menu Neelaka Molagoda, and Mirissa Hewage Dumindu Kavinda, and Yung Hyun Choi, and Hyesook Lee, and Chang-Hee Kang, and Mi-Hwa Lee, and Chang-Min Lee, and Gi-Young Kim
Department of Marine Life Science, Jeju National University, Jeju 63243, Korea.

Fine particulate matter (PM2.5) originates from the combustion of coal and is found in the exhaust of fumes of diesel vehicles. PM2.5 readily penetrates the skin via the aryl hydrocarbon receptor, causing skin senescence, inflammatory skin diseases, DNA damage, and carcinogenesis. In this study, we investigated whether fisetin, a bioactive flavonoid, prevents PM2.5-induced apoptosis in HaCaT human keratinocytes. The results demonstrated that fisetin significantly downregulated PM2.5-induced apoptosis at concentrations below 10 μM. Fisetin strongly inhibited the production of reactive oxygen species (ROS) and the expression of pro-apoptotic proteins. The PM2.5-induced apoptosis was associated with the induction of the endoplasmic reticulum (ER) stress response, mediated via the protein kinase R-like ER kinase (PERK)-eukaryotic initiation factor 2α (eIF2α)-activating transcription factor 4 (ATF4)-CCAAT-enhancer-binding protein (C/EBP) homologous protein (CHOP) axis. Additionally, the cytosolic Ca2+ levels were markedly increased following exposure to PM2.5. However, fisetin inhibited the expression of ER stress-related proteins, including 78 kDa glucose-regulated protein (GRP78), phospho-eIF2α, ATF4, and CHOP, and reduced the cytosolic Ca2+ levels. These data suggest that fisetin inhibits PM2.5-induced apoptosis by inhibiting the ER stress response and production of ROS.

UI MeSH Term Description Entries

Related Publications

Ilandarage Menu Neelaka Molagoda, and Mirissa Hewage Dumindu Kavinda, and Yung Hyun Choi, and Hyesook Lee, and Chang-Hee Kang, and Mi-Hwa Lee, and Chang-Min Lee, and Gi-Young Kim
July 2022, Antioxidants (Basel, Switzerland),
Ilandarage Menu Neelaka Molagoda, and Mirissa Hewage Dumindu Kavinda, and Yung Hyun Choi, and Hyesook Lee, and Chang-Hee Kang, and Mi-Hwa Lee, and Chang-Min Lee, and Gi-Young Kim
January 2016, International journal of nanomedicine,
Ilandarage Menu Neelaka Molagoda, and Mirissa Hewage Dumindu Kavinda, and Yung Hyun Choi, and Hyesook Lee, and Chang-Hee Kang, and Mi-Hwa Lee, and Chang-Min Lee, and Gi-Young Kim
December 2022, Redox report : communications in free radical research,
Ilandarage Menu Neelaka Molagoda, and Mirissa Hewage Dumindu Kavinda, and Yung Hyun Choi, and Hyesook Lee, and Chang-Hee Kang, and Mi-Hwa Lee, and Chang-Min Lee, and Gi-Young Kim
January 2022, Neurotoxicology,
Ilandarage Menu Neelaka Molagoda, and Mirissa Hewage Dumindu Kavinda, and Yung Hyun Choi, and Hyesook Lee, and Chang-Hee Kang, and Mi-Hwa Lee, and Chang-Min Lee, and Gi-Young Kim
January 2020, International journal of medical sciences,
Ilandarage Menu Neelaka Molagoda, and Mirissa Hewage Dumindu Kavinda, and Yung Hyun Choi, and Hyesook Lee, and Chang-Hee Kang, and Mi-Hwa Lee, and Chang-Min Lee, and Gi-Young Kim
January 2020, Oxidative medicine and cellular longevity,
Ilandarage Menu Neelaka Molagoda, and Mirissa Hewage Dumindu Kavinda, and Yung Hyun Choi, and Hyesook Lee, and Chang-Hee Kang, and Mi-Hwa Lee, and Chang-Min Lee, and Gi-Young Kim
April 2023, Journal of cosmetic dermatology,
Ilandarage Menu Neelaka Molagoda, and Mirissa Hewage Dumindu Kavinda, and Yung Hyun Choi, and Hyesook Lee, and Chang-Hee Kang, and Mi-Hwa Lee, and Chang-Min Lee, and Gi-Young Kim
October 2021, Basic & clinical pharmacology & toxicology,
Ilandarage Menu Neelaka Molagoda, and Mirissa Hewage Dumindu Kavinda, and Yung Hyun Choi, and Hyesook Lee, and Chang-Hee Kang, and Mi-Hwa Lee, and Chang-Min Lee, and Gi-Young Kim
March 2014, Molecular medicine reports,
Ilandarage Menu Neelaka Molagoda, and Mirissa Hewage Dumindu Kavinda, and Yung Hyun Choi, and Hyesook Lee, and Chang-Hee Kang, and Mi-Hwa Lee, and Chang-Min Lee, and Gi-Young Kim
October 2021, Experimental and therapeutic medicine,
Copied contents to your clipboard!